cilazapril, anhydrous has been researched along with Disease Models, Animal in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 13 (52.00) | 18.2507 |
| 2000's | 10 (40.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, JL; Hao, JB; Hao, LR; Ren, LS; Zhang, L | 1 |
| Cuzić, S; Knotek, M; Radović, N | 1 |
| Cui, SJ; Han, W; Huang, YL; Li, WM; Li, Y; Liang, ZJ; Wu, DL | 1 |
| Dong, D; Han, W; Li, B; Li, W; Li, Y; Sheng, L; Xue, J; Yang, B; Yang, S | 1 |
| Chu, S; Dong, D; Gong, YT; Han, W; Li, BX; Li, WM; Li, Y; Liu, W; Sheng, L; Xue, JY; Yang, BF; Zhang, L | 1 |
| Cui, RZ; Liu, GQ; Mao, YM; Sun, GY; Sun, J; Zhang, SS; Zhao, HM | 1 |
| Basal, S; Caglar, K; Eyileten, T; Ipcioglu, OM; Kaya, A; Korkmaz, A; Oguz, Y; Sonmez, A; Topal, T; Vural, A; Yenicesu, M; Yilmaz, MI | 1 |
| Liu, ZY; Sun, GY; Zhang, SS | 1 |
| Ogborn, MR; Pinette, G; Sareen, S | 1 |
| Abraham, WT; Badesch, DB; Bristow, MR; Gottschall, B; Groves, BM; Lowes, BD; Perryman, MB; Raynolds, MV; Voelkel, NF; Wynne, KM | 1 |
| Deng, LY; Larochelle, P; Schiffrin, EL | 1 |
| Bilsel, S; Dogan, N; Emerk, K; Erşahin, C; Haklar, G; Moini, H; Süngün, M; Yalçin, AS | 1 |
| Hirata, Y; Kondoh, K; Nakashima, M; Uematsu, T; Umemura, K | 1 |
| Bayar, MA; Erbengi, T; Iplikcioglu, AC; Sav, A | 1 |
| Kawai, S; Miyauchi, K; Okada, R; Yamaguchi, H | 1 |
| Kawachi, H; Kimura, H; Nakamura, T; Obata, J; Ohno, S; Shimizu, F; Yoshida, Y | 1 |
| Al-Qattan, KK; Ali, M; Alnaqeeb, MA; Khan, I | 1 |
| Patumraj, S; Udayachalerm, W; Vechakarn, O | 1 |
| Chen, J; Gu, Y; Lin, F; Lin, S; Yang, H; Zhu, C; Zhu, W | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
| Clozel, JP; Hefti, F; Kuhn, H | 1 |
| Clozel, JP; Fischli, W; Hess, P; Véniant, M | 1 |
| Chesebro, JH; Ferrell, M; Fuster, V; Gold, HK | 1 |
| Baumgartner, HR; Hefti, F; Kuhn, H; Müller, RK; Powell, JS; Rouge, M | 1 |
| Clozel, JP; Fischli, W | 1 |
3 review(s) available for cilazapril, anhydrous and Disease Models, Animal
| Article | Year |
|---|---|
Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
Topics: Adult; Aged; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Vessels; Cilazapril; Disease Models, Animal; Double-Blind Method; Drug Interactions; Female; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Vascular Resistance; Vasoconstriction | 1994 |
ACE-inhibitors and atherosclerosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Arteriosclerosis; Captopril; Cilazapril; Disease Models, Animal; Haplorhini; Hyperlipidemias; Lipid Metabolism; Peptidyl-Dipeptidase A; Pyridazines; Rabbits; Rats | 1992 |
Vascular protection with cilazapril in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Arterioles; Cilazapril; Disease Models, Animal; Hypertension; Pyridazines; Rats; Rats, Inbred SHR; Regional Blood Flow; Vascular Resistance | 1992 |
1 trial(s) available for cilazapril, anhydrous and Disease Models, Animal
| Article | Year |
|---|---|
Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
Topics: Adult; Aged; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Vessels; Cilazapril; Disease Models, Animal; Double-Blind Method; Drug Interactions; Female; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Vascular Resistance; Vasoconstriction | 1994 |
22 other study(ies) available for cilazapril, anhydrous and Disease Models, Animal
| Article | Year |
|---|---|
The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Cilazapril; Dialysis Solutions; Disease Models, Animal; Drug Therapy, Combination; Lymphocytes; Macrophages; Male; Mineralocorticoid Receptor Antagonists; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Fibrosis; Peritoneum; Peritonitis; Random Allocation; Rats; Rats, Wistar; Receptors, Mineralocorticoid; Spironolactone; Transforming Growth Factor beta1 | 2014 |
Effect of unilateral ureteral obstruction and anti-angiotensin II treatment on renal tubule and interstitial cell apoptosis in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Caspase 3; Cell Proliferation; Cell Survival; Cell Transdifferentiation; Cilazapril; Disease Models, Animal; Epithelial Cells; Kidney Tubules; Losartan; Male; Rats; Rats, Wistar; Ureteral Obstruction | 2008 |
[Effect of Cilazapril on endothelial cell function and fibrinolysis system in the canine atrial fibrillation models].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Cilazapril; Disease Models, Animal; Dogs; Endothelial Cells; Female; Fibrinolysis; Immunohistochemistry; Male; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 2005 |
Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Cilazapril; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Atria; Heart Conduction System; Male; Recovery of Function; Treatment Outcome; Ultrasonography | 2007 |
The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Blotting, Western; Calpain; Cilazapril; Disease Models, Animal; Dogs; Female; Gene Expression; Gene Expression Regulation; Heart Atria; Male; Myocytes, Cardiac; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Ultrasonography; Valine; Valsartan | 2007 |
[Effect of cilazapril and valsartan on the levels of cardiac interstitial water content in rats with acute myocardial infarction].
Topics: Animals; Antihypertensive Agents; Cilazapril; Disease Models, Animal; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1; Valine; Valsartan | 2007 |
Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Cilazapril; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Glutathione Peroxidase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbaric Oxygenation; Kidney; Male; Nephrotic Syndrome; Oxidative Stress; Protein Carbonylation; Proteinuria; Rats; Rats, Sprague-Dawley; Simvastatin; Superoxide Dismutase | 2008 |
[The study of the effect of Cilazapril and valsartan on angiotensin 1 and angiotensin 2 receptors mRNA expression and myocardial interstitial collagen metabolism after myocardial infarction in rats].
Topics: Animals; Cilazapril; Collagen; Disease Models, Animal; Male; Myocardial Infarction; Myocardium; Random Allocation; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2008 |
Cilazapril delays progression of hypertension and uremia in rat polycystic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cilazapril; Creatinine; Disease Models, Animal; Hypertension; Male; Polycystic Kidney Diseases; Rats; Rats, Inbred Strains; Uremia | 1995 |
Importance of angiotensin-converting enzyme in pulmonary hypertension.
Topics: Animals; Cilazapril; Disease Models, Animal; Electrophoresis, Agar Gel; Genotype; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Vascular Resistance; Ventricular Dysfunction, Right | 1995 |
Protective effects of cilazapril against free radical injury in myocardial ischaemia-reperfusion.
Topics: Animals; Cilazapril; Disease Models, Animal; Free Radical Scavengers; Free Radicals; Humans; Lipid Metabolism; Lipid Peroxidation; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Proteins; Rabbits | 1995 |
Experimental intimal thickening studies using the photochemically induced thrombosis model in the guinea-pig femoral artery.
Topics: Animals; Cell Division; Cilazapril; Disease Models, Animal; Femoral Artery; Guinea Pigs; Male; Muscle, Smooth, Vascular; Photochemistry; Thrombolytic Therapy; Thrombosis; Tunica Intima | 1994 |
Angiotensin-converting enzyme inhibitor cilazapril prevents chronic morphologic vasospasm in rat.
Topics: Animals; Chronic Disease; Cilazapril; Disease Models, Animal; Femoral Artery; Ischemic Attack, Transient; Male; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1994 |
Limitations of angiotensin-converting enzyme inhibitor in restenosis of a deep arterial injury model.
Topics: Angioplasty, Balloon; Angiotensin-Converting Enzyme Inhibitors; Animals; Cilazapril; Coronary Disease; Disease Models, Animal; Hyperplasia; Male; Rats; Rats, Sprague-Dawley; Recurrence; Tunica Intima | 1998 |
Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Cilazapril; Collagen; Disease Models, Animal; Glomerulonephritis, Membranoproliferative; Hydralazine; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Wistar; Renal Circulation; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta | 1999 |
Thromboxane-B2, prostaglandin-E2 and hypertension in the rat 2-kidney 1-clip model: a possible mechanism of the garlic induced hypotension.
Topics: Animals; Cilazapril; Dinoprostone; Disease Models, Animal; Down-Regulation; Garlic; Hypertension, Renovascular; Male; Phytotherapy; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Thromboxane B2; Time Factors; Water | 2001 |
Effects of ACE-I on diabetic cardiovascular complications: anti-hypertensive and non-antihypertensive doses.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Cilazapril; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Male; Probability; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity; Streptozocin | 2001 |
[The effects of endothelin blockade on renal expression of angiotensin II type 1 receptor in diabetic hypertensive rats].
Topics: Amlodipine; Animals; Antihypertensive Agents; Bosentan; Cilazapril; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelins; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfonamides | 2002 |
Effects of renin-angiotensin system blockade in guinea pigs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Bradykinin; Cilazapril; Cyclooxygenase Inhibitors; Disease Models, Animal; Furosemide; Guinea Pigs; Hypertension; Imidazoles; Indomethacin; Losartan; Nephrectomy; Oligopeptides; Pyridazines; Renin; Renin-Angiotensin System; Tetrazoles | 1992 |
A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Animals; Carotid Stenosis; Cilazapril; Coronary Disease; Disease Models, Animal; Pyridazines; Recurrence; Swine | 1992 |
The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Captopril; Cell Division; Cilazapril; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Growth Substances; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Pyridazines; Rats; Verapamil | 1990 |
Cyclosporin-induced hypertension in marmosets: a new model of hypertension sensitive to angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Callitrichinae; Cilazapril; Creatinine; Cyclosporins; Disease Models, Animal; Female; Heart Rate; Hypertension; Male; Pyridazines; Time Factors | 1989 |